Matthias J. Reddehase

Prof. Dr. Matthias J. Reddehase


Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1989 in Nature
Verified
Journal Article
Closed access
MRMatthias J. Reddehase
Matthias J. Reddehase
JRJonathan B. Rothbard
Jonathan B. Rothbard
UKUlrich H. Koszinowski
Ulrich H. Koszinowski

1 April 1989 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SJStipan Jonjić
Stipan Jonjić
WMW Mutter
W Mutter
FWF Weiland
F Weiland
MRMatthias J. Reddehase
Matthias J. Reddehase
UKU H Koszinowski
U H Koszinowski
We have established a murine model system for exploring the ability of a CD4 subset-deficient host to cope with cytomegalovirus infection, and reported three findings. First, an antiviral response of the CD8 subset of T lymphocytes could be not only initiated but also maintained for a long period of time despite a continued absence of the CD4 subset, whereas the production of antiviral antibody proved strictly dependent upon help provided by the CD4 subset. Second, no function in the defense against infection could be ascribed as yet to CD4-CD8- T lymphocytes, which were seen to accumulate to a new subset as a result of depletion of the CD4 subset. This newly arising subset did not substitute for CD4+ T lymphocytes in providing help to B lymphocytes, and was also not effective in controlling the spread of virus in host tissues. As long as a function of these cells in the generation and maintenance of a CD8 subset-mediated response is not disproved, caution is indicated with concern to an autonomy of the CD8 subset. Third, even though with delay, the CD8+ effector cells raised in the CD4 subset-deficient host were able of clear vital tissues from productive infection and to restrict asymptomatic, persistent infection to acinar glandular epithelial cells in salivary gland tissue.

1 November 2002 in Nature Reviews Immunology
Verified
Journal Article
Closed access
MRMatthias J. Reddehase
Matthias J. Reddehase

1 September 1991 in Cell
Verified
Journal Article
Closed access
MVMargarita Del Val
Margarita Del Val
HSHans-Jürgen Schlicht
Hans-Jürgen Schlicht
TRThomas Ruppert
Thomas Ruppert
MRMatthias J. Reddehase
Matthias J. Reddehase
UKUlrich H. Koszinowski
Ulrich H. Koszinowski

1 July 1989 in Cell
Verified
Journal Article
Closed access
CLChristophe Lurquin
Christophe Lurquin
APAline Van Pel
Aline Van Pel
BMBernard Mariamé
Bernard Mariamé
EPEtienne De Plaen
Etienne De Plaen
JSJean-Pierre Szikora
Jean-Pierre Szikora
TBThierry Boon
Thierry Boon

15 December 2000 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
RHRafaela Holtappels
Rafaela Holtappels
MPMarcus-Folker Pahl-Seibert
Marcus-Folker Pahl-Seibert
DTDoris Thomas
Doris Thomas
MRMatthias J. Reddehase
Matthias J. Reddehase
Interstitial cytomegalovirus (CMV) pneumonia is a clinically relevant complication in recipients of bone marrow transplantation (BMT). Recent data for a model of experimental syngeneic BMT and concomitant infection of BALB/c mice with murine CMV (mCMV) have documented the persistence of tissue-resident CD8 T cells after clearance of productive infection of the lungs (J. Podlech, R. Holtappels, M.-F. Pahl-Seibert, H.-P. Steffens, and M. J. Reddehase, J. Virol. 74:7496–7507, 2000). It was proposed that these cells represent antiviral “standby” memory cells whose functional role might be to help prevent reactivation of latent virus. The pool of pulmonary CD8 T cells was composed of two subsets defined by the T-cell activation marker L-selectin (CD62L): a CD62Lhisubset of quiescent memory cells, and a CD62Llosubset of recently resensitized memory-effector cells. In this study, we have continued this line of investigation by quantitating CD8 T cells specific for the three currently published antigenic peptides of mCMV: peptide YPHFMPTNL processed from the immediate-early protein IE1 (pp89), and peptides YGPSLYRRF and AYAGLFTPL, derived from the early proteins m04 (gp34) and M84 (p65), respectively. IE1-specific CD8 T cells dominated in acute-phase pulmonary infiltrates and were selectively enriched in latently infected lungs. Notably, most IE1-specific CD8 T cells were found to belong to the CD62Llosubset representing memory-effector cells. This finding is in accordance with the interpretation that IE1-specific CD8 T cells are frequently resensitized during latent infection of the lungs and may thus be involved in the maintenance of mCMV latency.